Replies to post #425 on Fate Therapeutics Inc (FATE)

[NY1972]

Did you see AvER in any publication? What is novel Avidity-enhancing Receptor (AvER) for superior CAR-dependent specificity and activity against tumor cells?

[jondoeuk]

BGNE are now developing their own*.

* iPSC-Derived CAR-Gamma Delta T with Novel Combinatorial KO Demonstrated Extended Longevity and Profound Anti-Tumor Efficacy without Cytokine Support in Preclinical Studies https://ash.confex.com/ash/2024/webprogram/Paper205086.html